Vogt Florian M, Antoch Gerald, Veit Patrick, Freudenberg Lutz S, Blechschmid Nina, Diersch Olaf, Bockisch Andreas, Barkhausen Jörg, Kuehl Hilmar
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Duisburg-Essen, Essen, Germany.
J Nucl Med. 2007 Nov;48(11):1836-44. doi: 10.2967/jnumed.107.042846. Epub 2007 Oct 17.
Rimlike contrast enhancement on morphologic imaging and increased tracer uptake on (18)F-FDG PET in the periphery of the necrosis can hamper differentiation of residual tumor from regenerative tissue after radiofrequency ablation of liver lesions. This study used MRI, CT, ultrasound, and (18)F-FDG PET/CT to assess the typical appearance of lesions in nontumorous animal liver tissue after radiofrequency ablation.
Lesions were created by radiofrequency ablation of normal liver parenchyma in 21 minipigs. Follow-up was performed by 3 contrast-enhanced morphologic modalities-MRI, CT, and ultrasound-and by (18)F-FDG PET/CT immediately, 3 and 10 d, and 1, 2, 3, and 6 mo after radiofrequency ablation. Images were evaluated qualitatively for areas of increased enhancement and regions of elevated tracer uptake. Furthermore, all images were assessed quantitatively by determination of ratios comparing enhancement/tracer uptake in the periphery of the necrosis with enhancement/tracer uptake in normal liver parenchyma. Imaging findings were compared with histopathology findings.
Immediately after radiofrequency ablation, no increase in (18)F-FDG uptake was visible, whereas elevated enhancement was noticed in the periphery of the necrosis on all morphologic imaging procedures. At further follow-up, an area of rimlike increase in (18)F-FDG uptake surrounding the necrosis was detected on PET/CT. The rimlike pattern of increased enhancement in the arterial phase was present for all liver lesions on CT, MRI, and ultrasound, especially between day 3 and month 1 after the radiofrequency ablation. Both elevated glucose metabolism and enhancement persisted for 6 mo postinterventionally. Histologic examination showed a hemorrhagic border converting into a regeneration capsule.
If performed immediately after radiofrequency ablation, (18)F-FDG PET/CT probably has benefits over those of morphologic imaging procedures when assessing liver tissue for residual tumor. Later follow-up may be hampered by visualization of peripheral hyperperfusion and tissue regeneration. Further studies on a patient population are essential.
肝脏病变射频消融后,坏死灶周边在形态学成像上呈环状强化,且在(18)F-FDG PET上示踪剂摄取增加,这可能会妨碍区分残留肿瘤与再生组织。本研究采用MRI、CT、超声以及(18)F-FDG PET/CT来评估动物非肿瘤性肝脏组织射频消融后病变的典型表现。
对21只小型猪的正常肝实质进行射频消融以制造病变。在射频消融后即刻、3天和10天以及1、2、3和6个月,通过3种增强形态学检查方法——MRI、CT和超声——以及(18)F-FDG PET/CT进行随访。对图像进行定性评估,观察强化增加区域和示踪剂摄取升高区域。此外,通过测定坏死灶周边强化/示踪剂摄取与正常肝实质强化/示踪剂摄取的比值,对所有图像进行定量评估。将影像学结果与组织病理学结果进行比较。
射频消融后即刻,未见(18)F-FDG摄取增加,而在所有形态学成像检查中,坏死灶周边均可见强化升高。在进一步随访中,PET/CT检测到坏死灶周围有一圈(18)F-FDG摄取增加。CT、MRI和超声上所有肝脏病变在动脉期均呈现环状强化增加模式,尤其是在射频消融后3天至1个月之间。干预后,葡萄糖代谢升高和强化持续6个月。组织学检查显示出血边界转变为再生包膜。
射频消融后即刻进行(18)F-FDG PET/CT检查,在评估肝脏组织有无残留肿瘤方面可能比形态学成像检查更具优势。后期随访可能会因外周高灌注和组织再生的显影而受到阻碍。对患者群体进行进一步研究至关重要。